CommercialCoverageMedium impact
Evoked Potentials 2.01.27
Excellus BlueCross BlueShield·Neurology, Neurosurgery, ENT (Ear, Nose & Throat) +2 more·Nervous Systems (Neurology)
Effective date
May 21, 2026
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield updated their evoked potentials policy defining medically appropriate indications for visual, somatosensory, and auditory evoked potentials, while marking vestibular evoked potentials and intraoperative visual evoked potential monitoring as investigational (non-covered). The policy specifies limited coverage for intraoperative neurophysiologic monitoring only during high-risk thyroid, parathyroid, spinal, intracranial, or vascular procedures.
Action Required
Before May 21, 2026: Billing team must review all evoked potential claims to ensure they meet the specific medical necessity criteria outlined in the policy. Update prior authorization requests to reference the approved indications for visual, somatosensory, and auditory evoked potentials. Stop billing for vestibular evoked myogenic potentials (cVEMPs and oVEMPs) and intraoperative visual evoked potential monitoring as these are now considered investigational. Providers must document that intraoperative neurophysiologic monitoring is only used during approved high-risk procedures (thyroid, parathyroid, spinal, intracranial, or vascular surgeries).